Commenting on the appointment, AUROBAC THERAPEUTICS CEO Florence Séjourné: “I am delighted that Martin is joining us. His incredibly strong knowledge and experience will be instrumental in helping us achieve our ambitious goals and making a profound impact in the field of antimicrobial resistance.”
AUROBAC THERAPEUTICS is proud to be a member of the BEAM Alliance
AUROBAC ©2025 – Legal Notice – Privacy Statement – Photo Credits – AUROBAC® is a registered trademark of AUROBAC THERAPEUTICS.